G-quadruplex c-myb gene targeting compounds (TetraGene)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameG-quadruplex c-myb gene targeting compounds (TetraGene)
Drug Alias Namec-myb gene inhibitors (TetraGene)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-myb expression inhibitors
TargetsTranscriptional activator Myb
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTetragene
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTetragene
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A